Table 2.
Disease characteristics | Number (%) |
---|---|
pT4 of primary tumour | 35 (23) |
Affected regional lymph nodes (N) | |
N0 (no affected regional lymph nodes) | |
N1 (1 to 3 affected regional lymph nodes) | 34 (22) |
N2 (more than 3 affected regional lymph nodes) | 61 (40) 59 (38) |
Vascular invasion | 22 (14) |
Perineal invasion | 25 (16) |
Lymphangiosis | 27 (17) |
Grade of differentiation | |
G1 (well) | 10 (6) |
G2 (medium) | 131 (85) |
G3 (poorly) | 13 (8) |
KRAS gen | |
non-mutated (wild-type) | 89 (58) |
mutated | 65 (42) |
KRAS mutation | |
codon 12 | 48 (73) |
codon 13 | 17 (27) |
BRAF gen | |
non-mutated (wild-type) | 150 (97) |
mutated | 4 (3) |